International Biotechnology Trust (LSE:IBT) Scaled Net Operating Assets : 1.00 (As of Feb. 2024)

View and export this data going back to 1994. Start your Free Trial

What is International Biotechnology Trust Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

International Biotechnology Trust's operating assets for the quarter that ended in Feb. 2024 was £311.54 Mil. International Biotechnology Trust's operating liabilities for the quarter that ended in Feb. 2024 was £6.59 Mil. International Biotechnology Trust's Total Assets for the quarter that ended in Aug. 2023 was £304.87 Mil. Therefore, International Biotechnology Trust's scaled net operating assets (SNOA) for the quarter that ended in Feb. 2024 was 1.00.

International Biotechnology Trust Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

International Biotechnology Trust's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Aug. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Aug. 2023 )
=	(Operating Assets (A: Aug. 2023 )	-	Operating Liabilities (A: Aug. 2023 ))	/	Total Assets (A: Aug. 2022 )
=	(304.871	-	2.08)	/	326.916
=	0.93

where

	Operating Assets		(A: Aug. 2023 )
=	Total Assets	-	Balance Sheet Cash And Cash Equivalents
=	304.871	-	0
=	304.871

	Operating Liabilities		(A: Aug. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	34.554	-	32.474	-	0
=	2.08

International Biotechnology Trust's Scaled Net Operating Assets (SNOA) for the quarter that ended in Feb. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Feb. 2024 )
=	(Operating Assets (Q: Feb. 2024 )	-	Operating Liabilities (Q: Feb. 2024 ))	/	Total Assets (Q: Aug. 2023 )
=	(311.542	-	6.591)	/	304.871
=	1.00

where

	Operating Assets		(Q: Feb. 2024 )
=	Total Assets	-	Balance Sheet Cash And Cash Equivalents
=	320.769	-	9.227
=	311.542

	Operating Liabilities		(Q: Feb. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	34.26	-	27.669	-	0
=	6.591

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

International Biotechnology Trust Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of International Biotechnology Trust's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

International Biotechnology Trust (LSE:IBT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » International Biotechnology Trust PLC (LSE:IBT) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

IBTl:UK

Address

65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ

Website

https://www.ibtplc.com

International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.